We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The company will begin marketing the technology in the U.S. in the coming weeks on a limited basis and is planning a national rollout by the end of March. Read More
The FDA grants breakthrough device status to novel medical devices that have the potential to provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. Read More
The first test available on BD’s newly CE-marked MX instrument is the BD CTGCTV2, which detects the three most prevalent nonviral sexually transmitted infections. Read More
High-quality evidence was lacking for most of the COVID-19 diagnostics, medical devices and drugs the FDA has granted Emergency Use Authorization (EUA) since the start of the pandemic, claimed researchers at Israel’s Tel-Aviv University in a provocative analysis in the journal JAMA Internal Medicine. Read More